William Beaumont Hospital

William Beaumont Hospital was paid $162.64M by Medicaid between Jan 2018 and Dec 2024, across 842 billing codes. Its largest line is 99285, emergency room visit (most serious) — 25% of everything it billed.

33Billing provider infoWILLIAM BEAUMONT HOSPITAL
ROYAL OAK, MI 48073

33aNPI1689653305assigned 01/11/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$162.64M

24GClaims6,223,420

24DCodes billed842

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Michigan

Rank by total paid#4 of 86

Median peer was paid$21.55M

This provider vs. median7.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official COX, MATTHEW controls 20+ related entities in our dataset. Read more

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	462,188	$17.11M
2019	704,571	$17.40M
2020	650,723	$17.92M
2021	1,049,860	$25.88M
2022	1,098,412	$30.28M
2023	1,177,167	$29.84M
2024incomplete	1,080,499	$24.21M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	25%	93,572	86,610	$40.93M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	10%	248,995	223,400	$16.98M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	5.4%	42,860	41,503	$8.79M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	2.6%	30,917	29,701	$4.17M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	2.2%	43,290	40,611	$3.52M
80061	Lipid panel	1.5%	195,525	194,803	$2.48M
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	1.5%	138,326	137,825	$2.37M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.3%	11,333	11,281	$2.19M
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	1.3%	53,893	16,085	$2.15M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.2%	83,291	23,994	$1.98M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.2%	92,684	90,885	$1.89M
42820	Tonsillectomy and adenoidectomy; younger than age 12	1.2%	709	707	$1.88M

830 more codes

87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	1.1%	90,686	$1.84M
84443	Thyroid stimulating hormone (TSH)	1.1%	186,587	$1.84M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.1%	39,714	$1.82M
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	7,054	$1.61M
80053	Comprehensive metabolic panel	<1%	294,975	$1.56M
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	36,080	$1.42M
82947		<1%	40,182	$1.32M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	11,731	$1.26M
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	2,635	$1.25M
96361	Intravenous infusion, hydration; each additional hour	<1%	30,061	$1.17M
71046	Radiologic examination, chest; 2 views	<1%	27,394	$1.12M
G0378	Hospital observation service, per hour	<1%	28,475	$1.10M
93975		<1%	10,192	$1.07M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	312,370	$1.05M
78815	Positron emission tomography (PET) for limited area imaging	<1%	1,517	$1.04M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	12,113	$944K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	4,900	$939K
83036	Hemoglobin; glycosylated (A1C)	<1%	158,604	$904K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	38,650	$887K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	2,828	$886K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	13,769	$880K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	8,964	$825K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	1,720	$817K
82607		<1%	88,037	$765K
70450	Computed tomography, head or brain; without contrast material	<1%	11,412	$732K
59025	Fetal non-stress test	<1%	8,698	$721K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	48,970	$670K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	42,271	$665K
96375	Therapeutic injection; each additional sequential IV push	<1%	33,983	$662K
20610		<1%	4,538	$656K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	13,573	$636K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	29,035	$616K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	8,064	$598K
80074		<1%	21,009	$593K
62323		<1%	1,929	$580K
41899	Unlisted procedure, dentoalveolar structures	<1%	402	$571K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	24,606	$504K
71045	Radiologic examination, chest; single view	<1%	15,343	$495K
76770		<1%	8,419	$482K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	557	$476K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	10,377	$463K
76830	Ultrasound, transvaginal	<1%	8,387	$458K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	3,434	$444K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	9,880	$442K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	8,270	$421K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	6,955	$415K
87086	Culture, bacterial; quantitative colony count, urine	<1%	102,053	$413K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	26,061	$409K
87480		<1%	34,348	$408K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	24,703	$403K
74183		<1%	2,154	$402K
82728		<1%	52,140	$402K
87660		<1%	33,809	$397K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	18,056	$376K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	4,386	$376K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	21,383	$371K
87510		<1%	31,981	$368K
36430		<1%	2,468	$366K
97162		<1%	7,744	$366K
84466		<1%	49,219	$362K
76801		<1%	6,407	$361K
93350		<1%	1,505	$356K
86003		<1%	5,467	$343K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	18,311	$340K
84439		<1%	60,855	$325K
77334		<1%	918	$323K
92587		<1%	2,372	$323K
83013		<1%	7,560	$321K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	4,957	$313K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	2,995	$312K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	1,139	$297K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	1,839	$297K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	167	$290K
84481		<1%	27,165	$288K
76819	Fetal biophysical profile; without non-stress testing	<1%	4,880	$288K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	3,833	$283K
92523		<1%	2,675	$277K
93970		<1%	3,131	$271K
86803		<1%	29,943	$270K
86900		<1%	24,049	$254K
71275	Computed tomographic angiography, chest, with contrast material	<1%	3,608	$249K
82746		<1%	30,481	$248K
87631		<1%	14,796	$245K
97116		<1%	15,754	$240K
90670		<1%	4,505	$239K
77066	Tomosynthesis, mammo	<1%	4,278	$237K
95700		<1%	1,304	$232K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,849	$232K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	23,162	$228K
76825		<1%	827	$221K
36415	Collection of venous blood by venipuncture	<1%	151,009	$216K
58558		<1%	178	$210K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	2,780	$210K
76642		<1%	5,422	$209K
20680		<1%	210	$206K
54161		<1%	647	$202K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	1,309	$199K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	258	$197K
97161		<1%	3,785	$196K
83540		<1%	51,951	$195K
80048	Basic metabolic panel (calcium, ionized)	<1%	82,454	$191K
19083		<1%	253	$190K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	436	$189K
85027		<1%	87,995	$186K
76536		<1%	3,797	$184K
86780		<1%	20,688	$179K
93458		<1%	132	$176K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	848	$172K
93971		<1%	3,631	$171K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	1,630	$171K
84403		<1%	10,715	$170K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	7,735	$170K
94060		<1%	1,233	$168K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	1,428	$167K
90472	Immunization administration, each additional vaccine (list separately)	<1%	9,940	$166K
93017		<1%	5,801	$164K
77065	Tomosynthesis, mammo	<1%	3,884	$163K
47562		<1%	49	$162K
84702		<1%	56,534	$162K
86769		<1%	6,687	$161K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	3,326	$154K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	5,656	$154K
27447		<1%	28	$153K
G0379	Direct admission of patient for hospital observation care	<1%	195	$151K
72141		<1%	1,424	$146K
77336		<1%	2,302	$146K
44970		<1%	49	$146K
C8921	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; complete	<1%	420	$144K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	11,654	$144K
83735		<1%	53,021	$142K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	400	$142K
27130		<1%	24	$141K
87070		<1%	29,323	$138K
49083		<1%	340	$138K
97166		<1%	2,838	$135K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	166	$133K
97165		<1%	2,376	$132K
95816		<1%	1,131	$128K
83970		<1%	5,841	$125K
58661		<1%	41	$123K
71250		<1%	2,382	$120K
87077		<1%	23,816	$111K
87632		<1%	2,159	$111K
87653		<1%	6,564	$111K
87186		<1%	23,813	$111K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	6,571	$111K
75574		<1%	1,937	$109K
97535	Self-care/home management training, each 15 minutes	<1%	7,698	$109K
86696		<1%	9,669	$109K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	65,371	$106K
73221		<1%	807	$103K
93308		<1%	1,219	$100K
86038		<1%	14,229	$99K
70491		<1%	994	$98K
84550		<1%	35,883	$98K
88184		<1%	1,710	$97K
77080		<1%	1,718	$95K
93880		<1%	1,569	$94K
72197		<1%	551	$91K
82670		<1%	5,434	$90K
83001		<1%	8,026	$89K
93798		<1%	1,673	$89K
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	<1%	5,507	$87K
84153		<1%	8,313	$83K
95951		<1%	221	$80K
87340		<1%	15,118	$79K
82043		<1%	22,959	$79K
87147		<1%	15,876	$77K
83880		<1%	9,199	$76K
84146		<1%	6,524	$75K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,487	$75K
86695		<1%	9,670	$74K
87529		<1%	3,247	$74K
72110		<1%	4,168	$74K
86480		<1%	2,448	$73K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	13,949	$72K
70486		<1%	1,878	$72K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	16,425	$71K
77300		<1%	462	$71K
83002		<1%	6,392	$70K
76881		<1%	1,220	$70K
94726		<1%	1,405	$69K
95716		<1%	183	$68K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	19,233	$67K
82784		<1%	8,255	$67K
86235		<1%	2,614	$66K
90686		<1%	5,470	$66K
81003		<1%	73,735	$65K
73560		<1%	7,380	$65K
87634		<1%	1,553	$65K
73564		<1%	4,133	$62K
Q0111	Wet mounts, including preparations of vaginal, cervical or skin specimens	<1%	2,345	$62K
97163		<1%	1,379	$61K
87522	Neg quan hep c or qual rna	<1%	2,613	$60K
83021		<1%	5,822	$59K
84402		<1%	4,142	$59K
70544		<1%	457	$58K
75561		<1%	296	$58K
86140		<1%	25,770	$58K
74019		<1%	4,015	$57K
82785		<1%	6,086	$57K
81001		<1%	51,959	$57K
73030		<1%	6,361	$56K
73502		<1%	4,495	$55K
90651		<1%	649	$55K
73610		<1%	5,958	$54K
31231		<1%	610	$54K
74018		<1%	3,242	$53K
29888		<1%	12	$51K
77063	Screening digital breast tomosynthesis, bilateral	<1%	4,190	$51K
83655		<1%	6,982	$49K
86762		<1%	6,615	$48K
81514		<1%	264	$48K
84478		<1%	2,112	$47K
83690		<1%	34,957	$47K
76882		<1%	1,407	$47K
80076		<1%	15,142	$47K
86592		<1%	15,743	$47K
88185		<1%	715	$46K
86376		<1%	5,145	$45K
71271		<1%	827	$44K
82627		<1%	3,277	$44K
82248		<1%	23,561	$44K
82550		<1%	15,896	$44K
84144		<1%	3,418	$43K
87536		<1%	1,059	$43K
84450		<1%	16,365	$43K
72100		<1%	3,293	$43K
86147		<1%	1,129	$42K
84460		<1%	14,977	$42K
73110		<1%	4,643	$42K
10005		<1%	126	$41K
19081		<1%	50	$41K
82565		<1%	16,003	$41K
85610		<1%	29,687	$41K
86787		<1%	5,874	$40K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	3,537	$40K
73130		<1%	5,231	$40K
93225		<1%	1,168	$39K
80051		<1%	9,765	$39K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	56	$39K
86706		<1%	6,583	$39K
82105		<1%	4,317	$39K
82570		<1%	16,002	$39K
82652		<1%	1,771	$38K
86665		<1%	2,463	$38K
96367		<1%	2,391	$38K
72156		<1%	272	$37K
73630		<1%	5,413	$37K
85652		<1%	28,157	$36K
86850		<1%	23,163	$36K
93296		<1%	2,136	$36K
73523		<1%	685	$36K
80069		<1%	10,115	$35K
73700		<1%	598	$34K
92586		<1%	468	$33K
83516		<1%	5,339	$33K
82274		<1%	3,520	$33K
88112		<1%	2,125	$33K
62321		<1%	106	$32K
72040		<1%	2,554	$31K
84425		<1%	2,501	$30K
82533		<1%	3,122	$30K
86200		<1%	3,965	$30K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	436	$30K
84520		<1%	14,383	$30K
74178		<1%	209	$30K
86800		<1%	3,224	$29K
86870		<1%	371	$29K
80081		<1%	781	$29K
73590		<1%	4,178	$29K
86160		<1%	2,311	$29K
31575		<1%	387	$27K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	135	$27K
77295		<1%	43	$27K
84100		<1%	15,284	$27K
72125	Computed tomography, cervical spine; without contrast material	<1%	3,039	$26K
86431		<1%	7,853	$26K
74022		<1%	3,136	$26K
88142		<1%	2,042	$25K
82378		<1%	2,380	$25K
72158		<1%	306	$24K
73140		<1%	2,009	$24K
82150		<1%	7,526	$24K
86146		<1%	878	$24K
10060		<1%	311	$23K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	68	$23K
88342		<1%	2,632	$23K
86141		<1%	2,860	$23K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	67	$23K
72070		<1%	1,651	$22K
52332		<1%	27	$22K
90732		<1%	257	$22K
92610		<1%	914	$22K
86225		<1%	2,900	$22K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	316	$22K
86704		<1%	3,450	$21K
90474		<1%	3,785	$21K
86828		<1%	647	$21K
G0475	Hiv antigen/antibody, combination assay, screening	<1%	1,702	$21K
84134		<1%	2,902	$21K
84445		<1%	689	$21K
73080		<1%	2,683	$21K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	80	$20K
80197		<1%	2,891	$20K
85730		<1%	15,812	$20K
94010		<1%	1,085	$20K
88307		<1%	1,832	$19K
73090		<1%	3,371	$19K
76870		<1%	1,646	$19K
80050	General health panel	<1%	1,312	$19K
54300		<1%	12	$19K
92579		<1%	1,605	$19K
84165		<1%	3,251	$19K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	7,406	$19K
86360		<1%	944	$19K
42830		<1%	14	$18K
25605		<1%	24	$18K
82247		<1%	7,462	$18K
20605		<1%	134	$18K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	805	$18K
86039		<1%	2,731	$17K
87427		<1%	2,102	$17K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	251	$17K
95909		<1%	118	$17K
83615		<1%	5,907	$17K
92557		<1%	533	$17K
87517		<1%	700	$17K
87205		<1%	9,373	$17K
95953		<1%	92	$17K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	237	$16K
87046		<1%	2,239	$15K
90677		<1%	233	$15K
86256		<1%	1,766	$15K
76000		<1%	635	$15K
92083		<1%	814	$15K
86359		<1%	946	$15K
73060		<1%	2,306	$15K
83525		<1%	2,093	$15K
82950		<1%	5,675	$15K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	213	$15K
85046		<1%	6,055	$14K
67028	Intravitreal injection of a pharmacologic agent	<1%	107	$14K
72170		<1%	866	$14K
86304		<1%	1,210	$14K
90716		<1%	628	$14K
92526		<1%	396	$14K
83090		<1%	1,445	$14K
86664		<1%	2,015	$14K
86334		<1%	1,094	$14K
77290		<1%	82	$13K
82310		<1%	4,148	$13K
84156		<1%	8,581	$13K
73552		<1%	2,333	$13K
87428		<1%	425	$13K
90750		<1%	92	$12K
86301		<1%	1,118	$12K
84484		<1%	35,548	$12K
C8908	Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral	<1%	63	$12K
84630		<1%	1,763	$12K
86663		<1%	2,022	$12K
91200		<1%	179	$11K
88341		<1%	1,390	$11K
72082		<1%	340	$11K
73070		<1%	1,430	$11K
90734		<1%	335	$11K
81025		<1%	9,608	$11K
86255		<1%	1,641	$11K
82977		<1%	3,053	$11K
85379		<1%	6,820	$11K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	24,820	$11K
74174		<1%	81	$11K
74230		<1%	185	$11K
83993		<1%	1,125	$11K
72146		<1%	130	$11K
82465		<1%	4,260	$10K
93923		<1%	165	$10K
82088		<1%	462	$10K
93299		<1%	660	$10K
82525		<1%	1,391	$10K
73562		<1%	613	$10K
95708		<1%	50	$10K
95910		<1%	77	$10K
86765		<1%	1,301	$10K
86901		<1%	22,667	$10K
83010		<1%	1,427	$10K
93270		<1%	736	$10K
88121		<1%	55	$9K
76506		<1%	188	$9K
52000		<1%	40	$9K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	5,740	$9K
87075		<1%	2,959	$9K
84432		<1%	885	$9K
95819		<1%	110	$9K
76885		<1%	238	$9K
86833		<1%	94	$9K
86832		<1%	94	$9K
87338		<1%	1,173	$9K
88304		<1%	2,444	$9K
86735		<1%	1,051	$9K
10022		<1%	32	$9K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	393	$8K
82270		<1%	117	$8K
29881		<1%	12	$8K
82040		<1%	3,756	$8K
77072		<1%	231	$8K
84075		<1%	2,863	$8K
80164		<1%	1,604	$8K
86708		<1%	1,306	$8K
82103		<1%	953	$8K
96376		<1%	20,146	$8K
80177		<1%	1,517	$7K
87045		<1%	2,197	$7K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	4,159	$7K
70487		<1%	89	$7K
82330		<1%	2,057	$7K
90744		<1%	909	$7K
76641		<1%	122	$6K
71101		<1%	411	$6K
87081		<1%	1,938	$6K
43235		<1%	16	$6K
82805		<1%	2,479	$6K
77470		<1%	37	$6K
84305		<1%	534	$6K
83921		<1%	509	$6K
87209		<1%	964	$6K
74455		<1%	54	$6K
73100		<1%	1,006	$6K
87449		<1%	1,738	$6K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	319	$6K
86923		<1%	1,325	$6K
92134		<1%	2,032	$5K
87324		<1%	1,564	$5K
92611		<1%	119	$5K
84155		<1%	2,831	$5K
87102		<1%	1,446	$5K
86644		<1%	711	$5K
73000		<1%	480	$5K
20600		<1%	30	$5K
93351		<1%	19	$5K
72050		<1%	134	$5K
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	<1%	350	$5K
92235		<1%	56	$5K
82985		<1%	396	$5K
87641		<1%	472	$5K
90671		<1%	324	$5K
87328		<1%	698	$5K
81002		<1%	4,533	$5K
82390		<1%	756	$5K
45384		<1%	12	$5K
82951		<1%	581	$4K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	16	$4K
82671		<1%	213	$4K
76820		<1%	2,733	$4K
87329		<1%	732	$4K
99496		<1%	67	$4K
83721		<1%	671	$4K
70360		<1%	287	$4K
88313		<1%	392	$4K
84132		<1%	3,311	$4K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	61	$4K
83521		<1%	230	$4K
82024		<1%	194	$4K
82157		<1%	283	$4K
62270		<1%	13	$4K
86364		<1%	637	$4K
87640		<1%	421	$4K
93246		<1%	228	$4K
90688		<1%	216	$4K
89051		<1%	2,389	$4K
62328		<1%	12	$4K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	136	$4K
86352		<1%	52	$4K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	89	$3K
86618		<1%	437	$3K
82962		<1%	8,524	$3K
P9612	Catheterization for collection of specimen, single patient, all places of service	<1%	154	$3K
36416		<1%	1,315	$3K
90656		<1%	375	$3K
64450		<1%	110	$3K
51798		<1%	1,031	$3K
87177		<1%	965	$3K
87535		<1%	136	$3K
83550		<1%	800	$3K
82677		<1%	244	$3K
92133		<1%	573	$3K
70498		<1%	118	$3K
85055		<1%	193	$3K
97014		<1%	340	$2K
77280		<1%	41	$2K
72052		<1%	55	$2K
99381		<1%	35	$2K
84244		<1%	186	$2K
81372		<1%	12	$2K
83704		<1%	131	$2K
90480		<1%	69	$2K
87040		<1%	4,663	$2K
10061		<1%	12	$2K
84154		<1%	192	$2K
86300		<1%	115	$2K
82164		<1%	289	$2K
86162		<1%	159	$2K
86922		<1%	654	$2K
92025		<1%	332	$2K
73620		<1%	428	$2K
95812		<1%	12	$2K
86356		<1%	231	$2K
86308		<1%	2,224	$2K
86336		<1%	267	$2K
85018		<1%	6,353	$2K
G0008	Administration of influenza virus vaccine	<1%	356	$2K
96127		<1%	187	$2K
86812		<1%	118	$2K
91322		<1%	15	$2K
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	<1%	103	$2K
93298		<1%	104	$2K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	21	$2K
82787		<1%	111	$2K
85014		<1%	4,963	$2K
83498		<1%	183	$2K
73565		<1%	4,764	$2K
92524		<1%	37	$2K
93797		<1%	23	$2K
90473		<1%	131	$2K
90739		<1%	12	$2K
43762		<1%	12	$1K
88173		<1%	432	$1K
93297		<1%	99	$1K
96450		<1%	13	$1K
82140		<1%	383	$1K
84300		<1%	1,018	$1K
83605		<1%	7,602	$1K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	1,120	$1K
72131		<1%	37	$1K
83722		<1%	125	$1K
90647		<1%	2,393	$1K
73521		<1%	55	$1K
87581		<1%	138	$1K
76886		<1%	28	$1K
59426		<1%	75	$1K
86005		<1%	126	$1K
76821		<1%	629	$1K
87486		<1%	135	$1K
86060		<1%	263	$1K
77370		<1%	26	$1K
87184		<1%	295	$1K
92250		<1%	205	$1K
84145		<1%	2,695	$1K
87541		<1%	118	$1K
84681		<1%	92	$1K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	57	$1K
93925		<1%	12	$1K
88262		<1%	26	$1K
85660		<1%	458	$1K
83014		<1%	195	$1K
76813		<1%	102	$1K
73120		<1%	162	$1K
57454		<1%	12	$1K
C1769	Guide wire	<1%	4,081	$997.75
86645		<1%	99	$977.88
92567		<1%	3,089	$968.75
14040		<1%	12	$963.03
80178		<1%	309	$955.19
G0109	Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes	<1%	22	$901.33
99382		<1%	14	$880.27
82952		<1%	378	$866.45
83930		<1%	1,038	$809.58
70480		<1%	13	$805.38
83520		<1%	539	$786.04
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	2,651	$771.54
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	8,431	$759.87
86905		<1%	16	$755.20
84703		<1%	3,683	$749.34
88312		<1%	244	$747.39
84295		<1%	1,289	$739.65
83718		<1%	148	$734.59
85045		<1%	333	$729.56
96415		<1%	15	$715.69
12001		<1%	401	$706.80
86593		<1%	264	$700.52
0173A		<1%	17	$662.89
85384		<1%	266	$620.69
80202		<1%	124	$592.62
90685		<1%	754	$586.35
83695		<1%	72	$580.46
82945		<1%	470	$553.46
84157		<1%	461	$530.41
85245		<1%	46	$525.58
73600		<1%	286	$517.41
86340		<1%	47	$484.67
85240		<1%	50	$474.58
85303		<1%	68	$469.21
82010		<1%	1,908	$467.11
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	2,386	$464.99
87015		<1%	348	$456.11
90658		<1%	26	$444.42
96381		<1%	29	$435.51
0071A		<1%	12	$427.61
82575		<1%	135	$415.21
90633		<1%	2,300	$414.66
93976		<1%	12	$407.82
85306		<1%	51	$405.59
82668		<1%	38	$402.27
82435		<1%	230	$394.15
C1889	Implantable/insertable device, not otherwise classified	<1%	1,808	$386.00
94644		<1%	68	$386.00
83630		<1%	38	$385.53
87109		<1%	40	$369.74
94760		<1%	2,844	$360.85
64447		<1%	39	$360.42
0124A		<1%	12	$359.82
85244		<1%	34	$350.79
82626		<1%	24	$345.32
85300		<1%	52	$341.72
82340		<1%	110	$339.19
94664		<1%	26	$336.90
86705		<1%	56	$313.65
86357		<1%	13	$313.25
86355		<1%	13	$313.25
82374		<1%	109	$305.51
88720		<1%	155	$299.77
97022		<1%	40	$278.00
82955		<1%	49	$276.67
86747		<1%	13	$244.19
J2785	Injection, regadenoson, 0.1 mg	<1%	1,798	$235.54
93280		<1%	32	$231.44
12011		<1%	328	$227.61
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	2,849	$225.75
83835		<1%	26	$221.28
J1644	Injection, heparin sodium, per 1000 units	<1%	19,959	$219.32
J0690	Injection, cefazolin sodium, 500 mg	<1%	12,658	$213.60
58300		<1%	12	$209.76
82542		<1%	180	$209.76
86317		<1%	28	$209.01
84163		<1%	38	$206.76
86702		<1%	24	$201.80
84133		<1%	164	$193.15
36000		<1%	44	$193.00
80175		<1%	52	$188.56
85007		<1%	93	$185.39
87076		<1%	54	$173.22
85613		<1%	38	$172.40
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	2,654	$160.39
82077		<1%	614	$150.19
87210		<1%	4,104	$145.78
85597		<1%	14	$141.48
86701		<1%	25	$139.96
84080		<1%	12	$121.17
76827		<1%	761	$117.57
73522		<1%	13	$114.60
97012		<1%	40	$114.55
84590		<1%	14	$104.38
87341		<1%	16	$102.03
87808		<1%	2,246	$101.39
82365		<1%	79	$99.60
99358	Prolong nursin fac eval 15m	<1%	431	$99.00
86709		<1%	15	$89.23
90723		<1%	2,391	$82.64
93242		<1%	12	$81.78
84255		<1%	12	$79.35
36591		<1%	13	$66.58
99177		<1%	181	$66.50
87493		<1%	13	$66.15
86902		<1%	28	$63.88
69210		<1%	28	$63.76
77073		<1%	12	$57.04
88311		<1%	142	$56.78
92136		<1%	12	$55.61
82948		<1%	258	$55.61
90662		<1%	15	$53.37
90715		<1%	4,801	$48.75
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	53,031	$48.40
88302		<1%	42	$43.93
J7120	Ringers lactate infusion, up to 1000 cc	<1%	42,309	$38.87
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	35,885	$33.61
85347		<1%	1,089	$33.40
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	8,695	$33.35
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	1,084	$31.84
J1170	Injection, hydromorphone, up to 4 mg	<1%	21,051	$29.66
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	26,778	$18.40
J2704	Injection, propofol, 10 mg	<1%	32,732	$18.09
81000		<1%	15	$16.77
86880		<1%	24	$16.28
83935		<1%	14	$13.19
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	7,269	$12.88
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	183	$12.12
J7030	Infusion, normal saline solution , 1000 cc	<1%	2,458	$10.98
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	855	$10.53
J2270	Injection, morphine sulfate, up to 10 mg	<1%	7,890	$10.17
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	34,582	$9.07
J3370	Injection, vancomycin hcl, 500 mg	<1%	3,479	$9.06
82800		<1%	297	$8.39
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	26,756	$7.95
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	2,845	$7.83
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	6,158	$7.10
J0780	Injection, prochlorperazine, up to 10 mg	<1%	2,861	$6.72
99188		<1%	48	$6.48
J0736	Injection, clindamycin phosphate, 300 mg	<1%	200	$5.60
J1940	Injection, furosemide, up to 20 mg	<1%	645	$4.89
C9113	Injection, pantoprazole sodium, per vial	<1%	4,511	$4.28
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	4,773	$3.19
J2550	Injection, promethazine hcl, up to 50 mg	<1%	2,784	$2.05
J2060	Injection, lorazepam, 2 mg	<1%	7,542	$1.95
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	7,382	$1.44
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	14,828	$1.21
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	27	$0.24
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	457	$0.24
90696		<1%	445	$0.02
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	256	$0.02
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	1,080	$0.02
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	203	$0.02
90680		<1%	3,381	$0.01
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	115	$0.01
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	2,058	$0.01
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	2,908	$0.01
J3480	Injection, potassium chloride, per 2 meq	0%	1,572	$0.00
J0461	Injection, atropine sulfate, 0.01 mg	0%	1,219	$0.00
95886		0%	1,328	$0.00
J0330	Injection, succinylcholine chloride, up to 20 mg	0%	3,005	$0.00
J1030	Injection, methylprednisolone acetate, 40 mg	0%	858	$0.00
J1040	Injection, methylprednisolone acetate, 80 mg	0%	1,773	$0.00
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	0%	2,670	$0.00
J7060	5% dextrose/water (500 ml = 1 unit)	0%	6,028	$0.00
J0131	Injection, acetaminophen, not otherwise specified,10 mg	0%	764	$0.00
A9270	Non-covered item or service	0%	4,313	$0.00
93320		0%	1,910	$0.00
90632		0%	338	$0.00
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	0%	1,829	$0.00
90698		0%	1,384	$0.00
A4648	Tissue marker, implantable, any type, each	0%	1,145	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	46	$0.00
97010		0%	93	$0.00
J1630	Injection, haloperidol, up to 5 mg	0%	3,207	$0.00
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	0%	96	$0.00
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	0%	142	$0.00
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	0%	225	$0.00
J7050	Infusion, normal saline solution, 250 cc	0%	854	$0.00
J3411	Injection, thiamine hcl, 100 mg	0%	1,458	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	981	$0.00
J3360	Injection, diazepam, up to 5 mg	0%	90	$0.00
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	0%	636	$0.00
J2360	Injection, orphenadrine citrate, up to 60 mg	0%	341	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	87	$0.00
74420		0%	113	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	63	$0.00
84270		0%	799	$0.00
J1836	Injection, metronidazole, 10 mg	0%	23	$0.00
94761		0%	193	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	96	$0.00
J3490	Unclassified drugs	0%	4,505	$0.00
80320		0%	117	$0.00
J7999	Compounded drug, not otherwise classified	0%	361	$0.00
C2617	Stent, non-coronary, temporary, without delivery system	0%	444	$0.00
91305		0%	28	$0.00
J0280	Injection, aminophyllin, up to 250 mg	0%	82	$0.00
J0360	Injection, hydralazine hcl, up to 20 mg	0%	126	$0.00
51600		0%	105	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	231	$0.00
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	0%	32	$0.00
A9573	Injection, gadopiclenol, 1 ml	0%	461	$0.00
99153	Mod sedat endo service >5yrs	0%	65	$0.00
36410		0%	27	$0.00
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	0%	95	$0.00
C1781	Mesh (implantable)	0%	26	$0.00
90619		0%	41	$0.00
29826		0%	12	$0.00
91317		0%	17	$0.00
J8501	Aprepitant, oral, 5 mg	0%	14	$0.00
77417		0%	19	$0.00
Q9965	Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml	0%	12	$0.00
83883		0%	46	$0.00
J7121	5% dextrose in lactated ringers infusion, up to 1000 cc	0%	52	$0.00
91307		0%	15	$0.00
L8699	Prosthetic implant, not otherwise specified	0%	15	$0.00
94618		0%	13	$0.00
58340		0%	16	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	3,062	$0.00
94729		0%	1,768	$0.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	1,511	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	279	$0.00
76937		0%	247	$0.00
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	0%	1,997	$0.00
C1776	Joint device (implantable)	0%	483	$0.00
93325		0%	3,706	$0.00
C1729	Catheter, drainage	0%	423	$0.00
Q9957	Injection, perflutren lipid microspheres, per ml	0%	345	$0.00
77002		0%	170	$0.00
J3475	Injection, magnesium sulfate, per 500 mg	0%	3,852	$0.00
76942		0%	1,760	$0.00
J1580	Injection, garamycin, gentamicin, up to 80 mg	0%	224	$0.00
80143		0%	204	$0.00
99354		0%	101	$0.00
J2800	Injection, methocarbamol, up to 10 ml	0%	882	$0.00
C1762	Connective tissue, human (includes fascia lata)	0%	125	$0.00
82610		0%	221	$0.00
J0735	Injection, clonidine hydrochloride, 1 mg	0%	664	$0.00
C1758	Catheter, ureteral	0%	66	$0.00
90707		0%	605	$0.00
J1650	Injection, enoxaparin sodium, 10 mg	0%	1,997	$0.00
J1050	Injection, medroxyprogesterone acetate, 1 mg	0%	1,526	$0.00
90700		0%	572	$0.00
95957		0%	385	$0.00
C8937	Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)	0%	26	$0.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	0%	664	$0.00
Q9958	High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml	0%	96	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	298	$0.00
C1760	Closure device, vascular (implantable/insertable)	0%	110	$0.00
C1780	Lens, intraocular (new technology)	0%	87	$0.00
76125		0%	149	$0.00
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	0%	360	$0.00
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	0%	43	$0.00
76001		0%	84	$0.00
80179		0%	193	$0.00
99152		0%	71	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	418	$0.00
90648		0%	12	$0.00
A9537	Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries	0%	25	$0.00
J1953	Injection, levetiracetam, 10 mg	0%	30	$0.00
95251		0%	14	$0.00
90461		0%	61	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	115	$0.00
C1788	Port, indwelling (implantable)	0%	12	$0.00
91312		0%	12	$0.00
93321		0%	46	$0.00
77387		0%	319	$0.00
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	0%	25	$0.00
82731		0%	12	$0.00
77003		0%	13	$0.00
90710		0%	19	$0.00
G8989	Self care functional limitation, discharge status, at discharge from therapy or to end reporting	0%	14	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCOX, MATTHEW (CHIEF FINANCIAL OFFICER)

Same official

Other billing entities under COX, MATTHEW

Full network →

Provider	Location	Paid
Spectrum Health Hospitals	Grand Rapids, MI	$243.22M
Oakwood Healthcare, INC.	Dearborn, MI	$165.61M
William Beaumont Hospital	Troy, MI	$84.88M
Lakeland Hospitals at Niles and ST Joseph, INC	Saint Joseph, MI	$78.22M
Botsford General Hospital	Farmington Hills, MI	$72.21M
William Beaumont Hospital	Grosse Pointe, MI	$61.49M
Oakwood Healthcare, INC.	Wayne, MI	$55.44M
Oakwood Healthcare, INC.	Taylor, MI	$50.28M
Oakwood Healthcare, INC.	Trenton, MI	$23.26M
Spectrum Health United	Greenville, MI	$20.99M
Mecosta County Medical Center	Big Rapids, MI	$19.50M
Pennock Hospital	Hastings, MI	$15.24M
Reed City Hospital Corporation	Reed City, MI	$15.02M
Zeeland Community Hospital	Zeeland, MI	$10.12M
Lakeland Community Hospital Watervliet	Watervliet, MI	$9.85M
Lakeland Community Hospital Watervliet	Niles, MI	$9.05M
Visiting Nurse Services of Western Michigan	Grand Rapids, MI	$4.54M
Lakeland Hospitals at Niles and ST Joseph, INC	Benton Harbor, MI	$3.33M
Banner Mesa Surgery Center LLC	Mesa, AZ	$2.80M
Lakeland Community Hospital Watervliet	Watervliet, MI	$2.55M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.